6.23
price down icon2.20%   -0.14
pre-market  시장 영업 전:  6.35   0.12   +1.93%
loading

Solid Biosciences Inc 주식(SLDB)의 최신 뉴스

pulisher
08:11 AM

Solid Biosciences receives FDA Fast Track designation for CPVT therapy - Investing.com

08:11 AM
pulisher
08:00 AM

Solid Biosciences Receives FDA Fast Track Designation for SGT-501 First-in-Class Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) - Stock Titan

08:00 AM
pulisher
04:10 AM

Solid Biosciences Inc. Stock Analysis and ForecastJaw-dropping returns - Autocar Professional

04:10 AM
pulisher
Jul 22, 2025

What drives Solid Biosciences Inc. stock priceFree Trading Psychology Coaching - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Is Solid Biosciences Inc. a good long term investmentExponentially increasing returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Cantor Fitzgerald Reaffirms Their Buy Rating on Solid Biosciences (SLDB) - The Globe and Mail

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Solid Biosciences Inc. stockFree Smart Trading Workshop - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Solid Biosciences Inc. shares rise 3.29% premarket after Senti Bio's presentation at BioScience Forum. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Cantor Fitzgerald reiterates Overweight rating on Solid Biosciences stock By Investing.com - Investing.com Canada

Jul 21, 2025
pulisher
Jul 21, 2025

Solid Biosciences stock rating reiterated at Market Outperform by JMP - Investing.com Canada

Jul 21, 2025
pulisher
Jul 19, 2025

What institutions are buying Solid Biosciences Inc. stock nowSteady Income Ideas - beatles.ru

Jul 19, 2025
pulisher
Jul 18, 2025

Solid Biosciences’ SWOT analysis: gene therapy stock shows promise amid challenges - Investing.com Nigeria

Jul 18, 2025
pulisher
Jul 17, 2025

Citi maintains Buy rating on Solid Biosciences stock amid Elevidys safety concerns - Investing.com Canada

Jul 17, 2025
pulisher
Jul 16, 2025

Why Solid Biosciences Inc. stock attracts strong analyst attentionSolid Return Trade Selections - beatles.ru

Jul 16, 2025
pulisher
Jul 15, 2025

Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), Solid Biosciences (SLDB) and Belite Bio, Inc. ADR (BLTE) - The Globe and Mail

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Solid Biosciences Inc. stock price move sharplyFree Investment Group - beatles.ru

Jul 15, 2025
pulisher
Jul 12, 2025

Cantor Fitzgerald Remains a Buy on Solid Biosciences (SLDB) - The Globe and Mail

Jul 12, 2025
pulisher
Jul 11, 2025

Solid Biosciences: SGT-003's Safety Profile Illuminates DMD Gene Therapy Path (Rating Upgrade) - Seeking Alpha

Jul 11, 2025
pulisher
Jul 10, 2025

Truist Financial Reaffirms Their Buy Rating on Solid Biosciences (SLDB) - The Globe and Mail

Jul 10, 2025
pulisher
Jul 10, 2025

SHAREHOLDER NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Solid Biosciences Inc. (NASDAQ: SLDB) and Encourages Long-Term SLDB Investors to Contact the Firm - The Victoria Advocate

Jul 10, 2025
pulisher
Jul 10, 2025

For Patients - Solid Biosciences

Jul 10, 2025
pulisher
Jul 09, 2025

Citi Initiates Coverage on Solid Biosciences Inc. (SLDB) with ‘Buy’ Rating and $14 PT - MSN

Jul 09, 2025
pulisher
Jul 09, 2025

Solid Biosciences: A Rare Gem in the Gene Therapy Race - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Solid Biosciences Inc. Initiated with 'Buy' Rating and $14 PT by Citi - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Solid Biosciences to begin testing SGT-501 in U.S. and Canada (SLDB) - Seeking Alpha

Jul 09, 2025
pulisher
Jul 09, 2025

Solid Biosciences cleared to begin phase I studies of SGT-501 in US and Canada - BioWorld MedTech

Jul 09, 2025
pulisher
Jul 09, 2025

Solid Biosciences Stock Pops On US, Canada Nod For Gene Therapy Trials: Retail Buzz Spikes - Stocktwits

Jul 09, 2025
pulisher
Jul 08, 2025

Solid Biosciences receives FDA approval for CPVT gene therapy IND By Investing.com - Investing.com South Africa

Jul 08, 2025
pulisher
Jul 08, 2025

Solid Biosciences receives FDA approval for CPVT gene therapy IND - Investing.com Australia

Jul 08, 2025
pulisher
Jul 08, 2025

Solid Biosciences gets FDA IND, Health Canada CTA nod for first-in-class cardiac gene therapy CPVT - MarketScreener

Jul 08, 2025
pulisher
Jul 08, 2025

Solid Biosciences Gets FDA, Health Canada Clearance to Advance Gene Therapy Trial for Cardiac Disease - MarketScreener

Jul 08, 2025
pulisher
Jul 08, 2025

Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy to Treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) - The Manila Times

Jul 08, 2025
pulisher
Jul 08, 2025

Breakthrough: First Gene Therapy for Fatal Heart Rhythm Disorder Advances to Clinical Trials - Stock Titan

Jul 08, 2025
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
자본화:     |  볼륨(24시간):